LOVELAND, Colo.--(BUSINESS WIRE)--Antech, the veterinary diagnostics company focused on partnering with veterinary professionals to predict, diagnose, and monitor wellness and disease, today announced the availability of two new breakthrough innovations to mark a new chapter for veterinary diagnostics.

科罗拉多州洛夫兰（商业新闻短讯）--兽医诊断公司Antech今天宣布推出两项新的突破性创新，标志着兽医诊断的新篇章。Antech专注于与兽医专业人员合作，预测，诊断和监测健康和疾病。

Available now are AIS RapidRead® to enable faster interpretations of radiographs and the in-house Nu.Q® Canine Cancer Test, two innovations that support clinical decision-making to improve patient outcomes..

AIS RapidRead®现在可用，可以更快地解释X光片和内部Nu.Q®犬癌症测试，这两项创新支持临床决策以改善患者预后。。

Nefertiti Greene, President, Mars Science & Diagnostics said:

火星科学与诊断总裁Nefertiti Greene表示：

“The launch of these new diagnostic innovations underscores Antech’s commitment to empowering more effective, efficient diagnostic decision-making for better health outcomes, in support of our purpose: A BETTER WORLD FOR PETS™.”

“这些新诊断创新的推出突显了Antech致力于为更好的健康结果提供更有效，更高效的诊断决策，以支持我们的目标：为宠物创造更美好的世界™。”

AIS RapidRead® is a new diagnostic tool coming out of Antech’s Artificial Intelligence (AI) pipeline, providing tested and reliable rapid imaging technology meaning an image can be read in minutes instead of days or hours. Developed by 20+ board-certified radiologists and a team of data scientists focused solely on next generation animal health products, AIS RapidRead® technology was trained on the world’s largest library of companion animal images, to provide veterinarians with an immediate radiology second opinion.

AIS RapidRead®是Antech人工智能（AI）管道中推出的一种新诊断工具，提供经过测试和可靠的快速成像技术，意味着图像可以在几分钟内读取，而不是几天或几小时。AIS RapidRead®技术由20多名经过董事会认证的放射科医生和一组专注于下一代动物保健产品的数据科学家开发，在世界上最大的伴侣动物图像库上接受了培训，为兽医提供了即时的放射学第二意见。

This transformative innovation has already had over 5,000 cases reviewed during a 2023 pilot program, helping in early detection, enhancing diagnoses and managing workflows..

在2023年的试点计划中，这项变革性创新已经审查了5000多个案例，有助于早期发现，增强诊断和管理工作流程。。

Lilly Ock, DVM, from VCA Animal Hospitals Urgent Care - Laguna Niguel, experienced AIS RapidRead® first-hand during the pilot phase and commented:

来自VCA动物医院紧急护理-拉古纳·尼格尔（Laguna Niguel）的DVM莉莉·奥克（Lilly Ock）在试点阶段亲身体验了AIS RapidRead®，并评论道：

“The AIS RapidRead® option for radiographs has made such a positive impact! Not only is the nearly instantaneous report a great facet but the information it provides is priceless to me. Having the option of image review to either confirm a differential diagnosis or draw attention to something that would be otherwise overlooked, is a huge comfort to my clients and me.”.

“AIS RapidRead®射线照片选项产生了如此积极的影响！几乎即时的报告不仅是一个很好的方面，而且它提供的信息对我来说是无价的。可以选择图像检查来确认鉴别诊断或提请注意其他可能被忽视的事情，这对我的客户和我来说都是一个巨大的安慰。”。

To further support veterinary professionals on their AI learning journey, Antech will be hosting two webinars on May 21 and 22, Lifting the Veil on Machine Learning in Veterinary Radiology to showcase the technology. The webinar will be offered May 21 and 22, and veterinary professionals can sign up here on Antech’s website..

为了进一步支持兽医专业人员的人工智能学习旅程，Antech将于5月21日和22日举办两次网络研讨会，揭开兽医放射学机器学习的面纱，展示这项技术。网络研讨会将于5月21日和22日举行，兽医专业人员可以在Antech的网站上注册。。

Also now available is Nu.Q® Canine Cancer Test, a rapid, accurate, targeted cancer screening tool for high-risk breeds and older dogs. Nu.Q® cancer detection includes prevalent types of canine cancers enabling veterinarians and pet owners to make informed decisions about cancer care more quickly. Studies1 have shown >75% detection rates for common cancers in dogs like lymphoma and hemangiosarcoma when using Nu.Q®.

现在还有Nu.Q®犬癌症检测，这是一种针对高危品种和老年犬的快速，准确，有针对性的癌症筛查工具。Nu.Q®癌症检测包括流行的犬类癌症类型，使兽医和宠物主人能够更快地做出有关癌症护理的明智决定。研究1显示，使用Nu.Q®时，淋巴瘤和血管肉瘤等犬常见癌症的检出率>75%。

As the only patient-side in-house test that provides accurate results from EDTA plasma in about six minutes, the Nu.Q® test is an aid to diagnosis that can be run in clinic by veterinary professionals during annual check-ups or regular senior wellness exams. Nu.Q® testing, run on the Element i+ analyzer, is both cost-effective and simple, requiring only 50µL of EDTA plasma from a patient..

Nu.Q®测试是唯一一种在六分钟内从EDTA血浆中获得准确结果的患者内部测试，可帮助兽医专业人员在年度检查或定期高级健康检查期间在临床上进行诊断。在Element i+分析仪上运行的Nu.Q®测试既经济又简单，只需要患者50µL EDTA血浆。。

Nu.Q® is a registered trademark of VolitionRx Limited and its subsidiaries. The Nu.Q® Canine Cancer Test is supplied under license by Belgian Volition SRL.

Nu.Q®是VolitinRx Limited及其子公司的注册商标。Nu.Q®犬癌症测试由比利时意志SRL授权提供。

About Mars Science & Diagnostics and Antech

关于火星科学与诊断和Antech

Mars Science & Diagnostics is a division of Mars Petcare, a diverse business dedicated to one purpose: A BETTER WORLD FOR PETS™. Science & Diagnostics brings together the power of leading pet health science with expertise across diagnostics, data, and technology to improve outcomes in pet health. Our veterinary diagnostics business Antech spans in-house diagnostic laboratory instruments and consumables, including rapid assay diagnostic products and digital cytology services; local and cloud-based data services; practice information management software and related software and support; 90+ reference laboratories around the globe; veterinary imaging and technology; education; and board-certified specialist support services.

Mars Science＆Diagnostics是Mars Petcare的一个部门，这是一家致力于一个目标的多元化企业：为宠物创造更美好的世界™。科学与诊断将领先的宠物健康科学的力量与诊断、数据和技术的专业知识结合在一起，以改善宠物健康的结果。我们的兽医诊断业务Antech涵盖内部诊断实验室仪器和耗材，包括快速检测诊断产品和数字细胞学服务；基于本地和云的数据服务；实践信息管理软件及相关软件和支持；全球90多个参考实验室；兽医成像和技术；教育；和董事会认证的专家支持服务。

Our at-home diagnostics offering includes Wisdom Panel, the world’s most accurate pet DNA test. For 60 years, our Waltham Petcare Science Institute has been advancing science to better understand pet health..

我们的家庭诊断产品包括世界上最准确的pet DNA测试Wisdom Panel。60年来，我们的沃尔瑟姆宠物护理科学研究所一直在推进科学，以更好地了解宠物健康。。

1 Wilson-Robles, H.M., Bygott, T., Kelly, T.K. et al. Evaluation of plasma nucleosome concentrations in dogs with a variety of common cancers and in healthy dogs. BMC Vet Res 18, 329 (2022). https://doi.org/10.1186/s12917-022-03429-8

1 Wilson-Robles，H.M.，Bygott，T.，Kelly，T.K.等人。评估患有多种常见癌症的狗和健康狗的血浆核小体浓度。BMC兽医第18329号决议（2022年）。https://doi.org/10.1186/s12917-022-03429-8